Description
Uses of medication: Nelarabine injection is a purine nucleoside analog and antineoplastic agent used primarily for the treatment of adults and children aged 1 year and older with specific types of T-cell cancers, such as T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Nelarabine 250 mg/50 mL (5 mg/mL) is prescribed for patients whose cancer has not improved with previous treatments or has recurred after at least two rounds of chemotherapy. It is part of a class of drugs called antimetabolites, which function by hindering the growth and reproduction of cancer cells.
Dosage & Side Effects of Nelarabine Injection:
The recommended dosage of Nelarabine injection varies based on the patient’s age and condition. For adults and adolescents aged 16 years and older, the typical dose is 1,500 mg/m² administered intravenously over two hours on days 1, 3, and 5 of a 21-day cycle. For children aged 1 to 21 years, the dose is 650 mg/m² administered intravenously over one hour daily for five consecutive days of a 21-day cycle. Always follow your healthcare provider’s instructions.
The most commonly reported side effects of Nelarabine injection include fatigue, nausea, vomiting, diarrhea, headache, dizziness, low blood cell counts, fever, and peripheral neuropathy (numbness or tingling in the hands and feet).